Musashi 2促进膀胱癌增殖及耐药的分子机制

81772714
2017
H1821.肿瘤治疗抵抗
侯腾
面上项目
副教授
华中科技大学
55万元
增殖;肿瘤干细胞;耐药;膀胱癌;2;Musashi
2018-01-01到2021-12-31
  • 中英文摘要
  • 结题摘要
  • 结题报告
  • 项目成果
  • 项目参与人
查看更多信息请先登录或注册
查看更多信息请先登录或注册
查看更多信息请先登录或注册
重置
序号 标题 类型 作者
1 RSPO3 promotes the aggressiveness of bladder cancer via Wnt/beta-catenin and Hedgehog signaling pathways 期刊论文 Chen Zhaohui;Zhou Lijie;Chen Liang;Xiong Ming;Kazobinka Gallina;Pang Zili;Hou Teng
2 circNUDT21 promotes bladder cancer progression by modulating the miR-16-1-3p/MDM2/p53 axis 期刊论文 Chen Liang;Li Wencheng;Li Zhiqin;Song Yarong;Zhao Jun;Chen Zhaohui;Kazobinka Gallina;Li Lulu;Xing Yifei;Hou Teng
3 Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis 期刊论文 Chen Liang;Yang Xiong;Zhao Jun;Xiong Ming;Almaraihah Raya;Chen Zhaohui;Hou Teng
4 NUDT21 promotes bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation 期刊论文 Xiong Ming;Chen Liang;Zhou Lijie;Ding Yong;Kazobinka Gallina;Chen Zhaohui;Hou Teng
5 Downregulation of NUDT21 contributes to cervical cancer progression through alternative polyadenylation 期刊论文 Xing Yifei;Chen Liang;Gu Haifeng;Yang Chenlu;Zhao Jun;Chen Zhaohui;Xiong Ming;Kazobinka Gallina;Liu Yaqiong;Hou Teng
查看更多信息请先登录或注册